Point72 (DIFC)’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,320
Closed -$3.77K 1791
2024
Q3
$3.77K Buy
+1,320
New +$3.7K ﹤0.01% 1313
2024
Q2
Sell
-4,585
Closed -$13K 1794
2024
Q1
$13K Buy
+4,585
New +$15.6K ﹤0.01% 1335

Other funds holding ORGO

Point72 (DIFC)'s ORGO Position: Q4 2024 in Review

Point72 (DIFC) sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 1,320 shares — an estimated $3.77K sold.

Point72 (DIFC) first reported a position in ORGO in Q1 2024 and held it in 2 quarters. The position peaked at $13K in Q1 2024. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Point72 (DIFC) reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Point72 (DIFC) sold 1,320 Organogenesis Holdings shares in Q4 2024, an estimated $3.77K.
  • Point72 (DIFC) first reported a position in Organogenesis Holdings in Q1 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Organogenesis Holdings position peaked at $13K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Point72 (DIFC)'s 13F filing for Q4 2024, filed 14 Feb 2025.